• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲抗生素耐药性不断演变的威胁:亚历山大项目的新数据

The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project.

作者信息

Schito G C, Debbia E A, Marchese A

机构信息

Institute of Microbiology, University of Genoa Medical School, Italy.

出版信息

J Antimicrob Chemother. 2000 Jul;46 Suppl T1:3-9. doi: 10.1093/oxfordjournals.jac.a020891.

DOI:10.1093/oxfordjournals.jac.a020891
PMID:10997593
Abstract

The Alexander Project was established in 1992 to examine the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens to a range of compounds. Since then it has expanded both geographically and in the number of antimicrobial agents tested. Within Europe, the most recent data have confirmed that the prevalence of penicillin resistance among isolates of Streptococcus pneumoniae is high in France and Spain, with both intermediate (MIC 0.12-1 mg/L) and resistant (MIC > or = 2 mg/L) phenotypes, and combined resistance rates of >50%. Macrolide resistance is increasing generally both among penicillin-resistant and penicillin-susceptible isolates of S. pneumoniae and its prevalence now exceeds that of penicillin resistance, overall (16.5% and 10.4%, respectively, in 1996; 21.9% and 14.1% in 1997; 16.5% and 11.6% in 1998). Beta-lactamase production was the principal mechanism of resistance observed among isolates of Haemophilus influenzae and Moraxella catarrhalis.

摘要

亚历山大项目于1992年设立,旨在研究社区获得性下呼吸道细菌病原体对一系列化合物的抗菌敏感性。自那时起,该项目在地理范围和所检测抗菌药物的数量上均有所扩展。在欧洲,最新数据证实,法国和西班牙的肺炎链球菌分离株中青霉素耐药率很高,同时存在中度(最低抑菌浓度0.12 - 1毫克/升)和耐药(最低抑菌浓度≥2毫克/升)表型,联合耐药率超过50%。肺炎链球菌的青霉素耐药和青霉素敏感分离株中,大环内酯类耐药性总体上都在增加,目前其流行率超过了青霉素耐药率(1996年分别为16.5%和10.4%;1997年为21.9%和14.1%;1998年为16.5%和11.6%)。β-内酰胺酶产生是在流感嗜血杆菌和卡他莫拉菌分离株中观察到的主要耐药机制。

相似文献

1
The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project.欧洲抗生素耐药性不断演变的威胁:亚历山大项目的新数据
J Antimicrob Chemother. 2000 Jul;46 Suppl T1:3-9. doi: 10.1093/oxfordjournals.jac.a020891.
2
The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.1996 - 1997年亚历山大项目:这项关于社区获得性下呼吸道感染细菌病原体的国际研究的最新药敏数据。
J Antimicrob Chemother. 2000 Feb;45(2):191-203. doi: 10.1093/jac/45.2.191.
3
Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996.细菌性呼吸道病原体的抗菌药物敏感性趋势——1992 - 1996年亚历山大项目的研究结果
J Chemother. 1999 Feb;11 Suppl 1:5-21. doi: 10.1179/joc.1999.11.Supplement-2.5.
4
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.1998 - 2000年亚历山大项目:社区获得性呼吸道感染分离病原体对常用抗菌药物的敏感性
J Antimicrob Chemother. 2003 Aug;52(2):229-46. doi: 10.1093/jac/dkg321. Epub 2003 Jul 15.
5
Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents.加拿大分离出的流感嗜血杆菌、卡他莫拉菌和肺炎链球菌对口服抗菌药物的敏感性。
Int J Antimicrob Agents. 2001 Jun;17(6):457-64. doi: 10.1016/s0924-8579(01)00334-x.
6
Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.2002/3年间英国社区获得性呼吸道病原体的抗菌药敏性,通过英国抗菌化疗学会(BSAC)方法在当地和中央进行测定。
J Antimicrob Chemother. 2005 Feb;55(2):200-8. doi: 10.1093/jac/dkh540. Epub 2005 Jan 13.
7
Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance.从社区获得性下呼吸道感染成年患者中分离出的肺炎链球菌、流感嗜血杆菌和卡他莫拉菌菌株对司帕沙星及其他抗生素的敏感性:一项欧洲多中心研究。SPAR研究组。抗生素耐药性监测计划。
J Antimicrob Chemother. 1998 Feb;41(2):207-14. doi: 10.1093/jac/41.2.207.
8
A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project.1992 - 1993年社区获得性下呼吸道病原体抗菌药物敏感性多中心协作研究:亚历山大项目
J Antimicrob Chemother. 1996 Jul;38 Suppl A:1-57. doi: 10.1093/jac/38.suppl_a.1.
9
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].[2009年至2010年期间从中国成年人中分离出的社区获得性呼吸道病原体的抗菌药敏性]
Zhonghua Jie He He Hu Xi Za Zhi. 2012 Feb;35(2):113-9.
10
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.1997 - 1998年亚洲和欧洲分离出的肺炎链球菌、流感嗜血杆菌和卡他莫拉菌的耐药性监测
J Antimicrob Chemother. 2000 Apr;45(4):457-66. doi: 10.1093/jac/45.4.457.

引用本文的文献

1
Severe problem of macrolides resistance to common pathogens in China.中国常见病原体对大环内酯类药物的耐药性严重。
Front Cell Infect Microbiol. 2023 Aug 10;13:1181633. doi: 10.3389/fcimb.2023.1181633. eCollection 2023.
2
A computational model to monitor and predict trends in bacterial resistance.一种用于监测和预测细菌耐药性趋势的计算模型。
J Glob Antimicrob Resist. 2015 Sep;3(3):174-183. doi: 10.1016/j.jgar.2015.04.006. Epub 2015 Jun 3.
3
Is nationwide special campaign on antibiotic stewardship program effective on ameliorating irrational antibiotic use in China? Study on the antibiotic use of specialized hospitals in China in 2011-2012.
全国性抗生素管理计划专项活动对改善中国抗生素不合理使用是否有效?2011 - 2012年中国专科医院抗生素使用情况研究。
J Huazhong Univ Sci Technolog Med Sci. 2014 Jun;34(3):456-463. doi: 10.1007/s11596-014-1300-6. Epub 2014 Jun 18.
4
Antibiotic resistance in primary care in Austria - a systematic review of scientific and grey literature.奥地利初级保健中的抗生素耐药性 - 科学和灰色文献的系统评价。
BMC Infect Dis. 2011 Nov 28;11:330. doi: 10.1186/1471-2334-11-330.
5
Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.多重耐药肺炎链球菌感染:当前及未来的治疗选择
Drugs. 2007;67(16):2355-82. doi: 10.2165/00003495-200767160-00005.
6
Comparison of Clarithromycin and Amoxicillin/Clavulanic Acid for Community-Acquired Pneumonia in an Era of Drug-Resistant Streptococcus pneumoniae.比较耐药肺炎链球菌流行时期的克拉霉素和阿莫西林/克拉维酸治疗社区获得性肺炎的效果。
Clin Drug Investig. 2003;23(8):491-501. doi: 10.2165/00044011-200323080-00001.
7
Gram-positive cocci infections in intensive care: guide to antibacterial selection.重症监护中的革兰氏阳性球菌感染:抗菌药物选择指南
Drugs. 2006;66(6):751-68. doi: 10.2165/00003495-200666060-00003.
8
Properties of novel international drug-resistant pneumococcal clones identified in day-care centers of Lisbon, Portugal.在葡萄牙里斯本日托中心发现的新型国际耐药肺炎球菌克隆株的特性
J Clin Microbiol. 2005 Sep;43(9):4696-703. doi: 10.1128/JCM.43.9.4696-4703.2005.
9
Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671].降钙素原指导下的抗生素使用与基层医疗中急性呼吸道感染的标准治疗方法对比:一项随机对照试验的研究方案及参与研究的全科医生的基线特征 [国际标准随机对照试验编号:ISRCTN73182671]
BMC Fam Pract. 2005 Aug 18;6:34. doi: 10.1186/1471-2296-6-34.
10
Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.2001年至2003年期间八个欧洲国家肺炎链球菌的抗菌药物敏感性
Antimicrob Agents Chemother. 2005 Jul;49(7):2903-13. doi: 10.1128/AAC.49.7.2903-2913.2005.